Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An instance of prekallikrein deficiency that is caused by an inherited modification of the individual's genome.
Features include always present findings: Reduced circulating prekallikrein concentration and Prolonged partial thromboplastin time. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 1 | Abnormal bleeding tendency (abnormal bleeding) |
KLKB1 encodes kallikrein B1 (638 aa). Participates in the surface-dependent activation of blood coagulation. Activates, in a reciprocal reaction, coagulation factor XII/F12 after binding to negatively charged surfaces. Highest expression in Liver (76.5 TPM) and Kidney Medulla (9.3 TPM).
Inherited prekallikrein deficiency is caused by mutations in the KLKB1 gene on chromosome 4.
The KLKB1 protein participates in prekallikrein + kininogen - prekallikrein:kininogen, prekallikrein:kininogen:cell surface receptor:factor XII - factor XIIa + prekallikrein:kininogen:cell surface receptor (FXII autocatalysis on the cell surface), and FXI + kininogen - FXI:kininogen pathways.
KLKB1 is classified as a druggable target (Druggable Genome, Enzyme, and Protease categories) with score 11.2.
Genetic testing for KLKB1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for inherited prekallikrein deficiency.
4 publications have been identified in PubMed for inherited prekallikrein deficiency. Kisho has analyzed 3 by research type. Research spans Case Report / Case Series (67%) and Review / Meta-Analysis (33%).
Iwai T (2026). [PMID: 41123211](https://pubmed.ncbi.nlm.nih.gov/41123211/). *Anaesth Intensive Care*. [Case Report / Case Series]
Rocca B (2025). [PMID: 40309219](https://pubmed.ncbi.nlm.nih.gov/40309219/). *Eur Cardiol*. [Case Report / Case Series]
Fasshauer M (2024). [PMID: 39502954](https://pubmed.ncbi.nlm.nih.gov/39502954/). *Allergol Select*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 11:57 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center